FH...you raise an interesting point. Most people in the world cannot afford the very expensive treatments...and most governments and hospitals in the world are looking for "affordable health care".
However at this point it is IMO too soon to say that the more expensive treatments are better! The HS-110 plus Opdivo results are looking very good so far. We shall soon see how good the HS-110 plus low dose CPA are. Low dose generic CPA would be very inexpensive.
I have no idea how expensive the ComPACT(gp96 plus Ox40)technology is. I would think the combination would be cheaper than the two drugs used separately...and the preclinical indicates that the ComPACT combination is more effective!
And is PTX-25 cost efficient? I have no idea. And what about Shattuck Labs new checkpoint and co-stimulator combination? Might it be cost saving as well?
I have never been a fan of excellent health care for the rich and shabby health care for the poor...if HTBX can help make excellent health care available for all...all the better!
News 
Market Data 
Discover 
